RVMD Since 2020 Annualized Return and Average Annual Return

RVMD Average Annual Return Chart Since 2020
Growth of $10,000.00
Without Dividends Reinvested Into RVMD

Also see:
• RVMD stock yearly return 2021
• RVMD stock yearly return 2022
• RVMD stock yearly return 2023
• RVMD stock yearly return 2024
• RVMD stock yearly return 2025
• RVMD YTD return
Average Annual Return Benchmarks
Compare RVMD average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
RVMD Share Performance
RVMD Average Annual Return Table Since 2020
Start date: 02/14/2020
End date: 05/08/2026
Start price/share: $28.31
End price/share: $141.81
Dividends collected/share: $0.00
Total return: 400.92%
RVMD Average Annual Return: 29.51%
Starting investment: $10,000.00
Ending investment: $50,080.07
Years: 6.23


RVMD average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Revolution Medicines Inc
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The RVMD average annual return since 2020 is shown above.

The Average Annual Return on the RVMD average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether RVMD average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RVMD average annual return calculation with any dividends reinvested as applicable (on ex-dates).
RVMD Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree RVMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Revolution Medicines (RVMD) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

RVPH Average Annual Return
RVTY Average Annual Return
RXRX Average Annual Return
RXST Average Annual Return
RYTM Average Annual Return
RZLT Average Annual Return
SABS Average Annual Return
SANA Average Annual Return
SBFM Average Annual Return
SCYX Average Annual Return
More Healthcare companies »
 

RVMD Average Annual Return Since 2020 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.